Iterum Therapeutics Q3 EPS $(2.15) Down From $(1.24) YoY

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(2.15) per share. This is a 73.39 percent decrease over losses of $(1.24) per share from the same period last year.

Benzinga · 11/12/2019 22:01

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(2.15) per share. This is a 73.39 percent decrease over losses of $(1.24) per share from the same period last year.